Predictors of Limb Fat Gain in HIV Positive Patients Following a Change to Tenofovir-Emtricitabine or Abacavir-Lamivudine

BACKGROUND: Antiretroviral treatment (cART) in HIV causes lipoatrophy. We examined predictors of anthropometric outcomes over 96 weeks in HIV-infected, lipoatrophic adults receiving stable cART randomised to tenofovir-emtricitabine (TDF-FTC) or abacavir-lamivudine (ABC-3TC) fixed dose combinations....

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Allison, Amin, Janaki, Emery, Sean, Baker, David, Carr, Andrew, Cooper, David A., Bloch, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203920/
https://www.ncbi.nlm.nih.gov/pubmed/22046394
http://dx.doi.org/10.1371/journal.pone.0026885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203920/
https://www.ncbi.nlm.nih.gov/pubmed/22046394
http://dx.doi.org/10.1371/journal.pone.0026885

Ejemplares similares